Andrew Huberman But I appreciate that you mentioned the duration of the study because, in thoroughness, which you're characterized for, people should know it
As a practitioner, Jennifer knew that if Daniell saw a red flag in any part of her plan, that protocol would be much less successful for her
Semaglutide (STEP 1 trial): Participants lost an average of 14.9% of body weight over 68 weeks at the 2.4 mg dose, compared to 2.4% with placebo
All medications come from licensed 503A compounding pharmacies, with no insurance required and HSA/FSA eligibility
Cardiometabolic Benefits Beyond Blood Sugar Control Although glucose control remains important, the broader benefits of GLP-1 therapies cannot be ignored
Heres what it can do: Supports gut health BPC-157 helps strengthen the stomach lining and has been shown to protect against ulcers, acid reflux, and leaky gut